Skip to main content

Table 2 Reported prevalence of Anti-HBc, HBV DNA and OBI in HBsAg Negative blood donors based on some published studies in Iran

From: Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors

Reference City Number of donors (HBsAg-) Anti-HBc+ n (%) HBV DNA+/Anti-HBc+ n (%) OBI n (%)
Sofian et al. [12] Arak 531 11(2.1 %) 0/11 (0 %) 0
Shahabi et al. a Mashhad 5059 432(8.5 %) 0/60 (0 %) 0
AminiKafi-abad et al. [13] Tehran 2000 230 (11.5) 0/230 (0 %) 0
Khamesipour et al. [14] Rasht 2041 78 (3.8 %) 1/78 (1.3 %) 1 (0.05 %)
Pourazar et al. [15] Isfahan 545 43 (8 %) 5/43 (11.62 %) 5 (0.92 %)
Behbahani et al. [16] Shiraz 2000 131 (6.55 %) 16/131 (12.2 %) 16 (0.8 %)
Arababadi et al. [17] a Rafsanjan 3700 352 (9.51 %) 57/352 (16.1 %) 57 (1.54 %)
Jafarzadeh et al. [18] Rafsanjan 270 14 (5.18 %) 4/14 (28.57 %) 4 (1.48 %)
Delavari et al. [19] Kerman 1525 121 (8 %) 36/121 (29.7 %) 36 (2.36 %)
Vaezjalali et al. [20] Tehran 1000 80 (8 %) 40/80 (50 %) 40 (4 %)
Alizadeh et al. [21] Tehran 5000 499 (9.8 %) 2/499 (0.4 %) 2 (0.04 %)
Total 23,671 1991 (8.4 %) 161 (9.9 %) 161 (0.7 %)
  1. a Article published in Persian